Endothelial and Microvascular Functions in Patients With Myocardial Ischemia
NCT ID: NCT03243968
Last Updated: 2017-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2014-03-01
2015-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Association Between Systemic Microvascular Endothelial Function and Coronary Physiology Indexes
NCT05864729
Evaluation of Systemic Microvascular Endothelial Dysfunction in Patients Presenting With Infective Endocarditis
NCT02940340
Role of Endothelial Biomarkers in Patients With Coronary Artery Disease
NCT03146208
Biomarkers of Inflammation and Endothelial Dysfunction in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries
NCT06446895
EARLY-MYO-Myocarditis Registry
NCT04338113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ischemic patient - IP
25 participants with myocardial ischemia detected by scintigraphy and normal coronarography
No interventions assigned to this group
Control group - CG
25 healthy non-ischemic individuals
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Camillo L.C. Junqueira
UNKNOWN
Esmeralci Ferreira
UNKNOWN
Maria das Graças C. Souza
UNKNOWN
Eliete Bouskela
UNKNOWN
Rio de Janeiro State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Alexandre Bottino
MD and PHD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Biovasc isquêmicos
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.